Advisory Council for the Elimination of Tuberculosis (ACET) Meeting; Correction, 2229 [2019-01205]

Download as PDF Federal Register / Vol. 84, No. 25 / Wednesday, February 6, 2019 / Notices Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis (ACET) Meeting; Correction Notice is hereby given of a change in the meeting of the Advisory Council for the Elimination of Tuberculosis (ACET): December 11, 2018, 8:30 a.m. to 4:30 p.m., EDT which was published in the Federal Register on November 2, 2018 Volume 83, Number 213, pages 55172. The time for December 11, 2018, 8:30 a.m. to 4:30 p.m., EST should read as follows: 10:00 a.m. to 4:30 p.m., EST. FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E–07, Atlanta, Georgia 30329, telephone (404) 639–8317; zkr7@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–01205 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), ICD–10 Coordination and Maintenance (C&M) Committee Meeting Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: The CDC, National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the following meeting of the ICD–10 Coordination and Maintenance (C&M) Committee meeting. This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. We will be broadcasting the meeting live via Webcast at http:// www.cms.gov/live/. amozie on DSK3GDR082PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 18:09 Feb 05, 2019 Jkt 247001 The meeting will be held on March 5, 2019, 9:00 a.m. to 5:00 p.m. EST and March 6, 2019, 9:00 a.m. to 5:00 p.m. EST. ADDRESSES: Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244. FOR FURTHER INFORMATION CONTACT: Traci Ramirez, Program Specialist, CDC, 3311 Toledo Rd. Hyattsville, Maryland 20782 telephone (301) 458–4454; TRamirez@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The ICD–10 Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Tenth Revision, Clinical Modification and ICD–10 Procedure Coding System. Matters To Be Considered: The tentative agenda includes discussions on ICD–10–CM and ICD–10–PCS topics listed below. Agenda items are subject to change as priorities dictate. Please refer to the posted agenda for updates one month prior to the meeting. DATES: DEPARTMENT OF HEALTH AND HUMAN SERVICES ICD–10–PCS Topics Administration of caplacizumab Administration of fosfomycin (CONTEPO®) Administration of gilteritinib (XOSPATA®) Administration of imipenem, cilastatin, relbactam (fixed dose combination) (IMI/REL) Administration of imlifidase (IdefirixTM) Administration of iobenguane I 131 (AZEDRA®) Administration of ruxolitinib (Jakafi®) Administration of tagraxofusp; SL–401 (ELZONRISTM) Administration of venetoclax (VENCLEXTA®) Brachytherapy Device (CivaSheet®) Cerebral Embolic Protection Device (CEPD) (TriGuard 3TM) Endovascular Arteriovenous Fistula (endoAVF) Creation with magneticGuided Radiofrequency Energy and Embolization Extracorporeal Membrane Oxygenation (ECMO) (intraoperative ECMO) injectable_Implantable Allograft (Flo¯Graft®) (XWRAP®) (Flo¯Graft®Neogenesis) Insertion of Sustained Release DrugEluting Stent (ELUVIATM) multiplex diagnostic panel (T2 Bacteria Test Panel) Addenda and Key Updates ICD–10–CM Topics Babesiosis Congenital Vascular Hematomas and Hemangiomas PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 2229 Corneal Dystrophy Juvenile Osteochondrosis of Tibia and Fibula Macular Hole Expansion Neonatal Cerebral Infarction Osteopenia of Hip Sjogren Syndrome Social Determinants of Health Unspecified Use of Alcohol or Cocaine with Withdrawal ICD–10–CM Addendum Security Considerations: Due to increased security requirements, CMS has instituted stringent procedures for entrance into the building by nongovernment employees. Attendees will need to present valid government-issued picture identification, and sign-in at the security desk upon entering the building. Attendees who wish to attend the March 5–6, 2019, ICD–10–CM C&M meeting must submit their name and organization by February 22, 2019, for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by security to admit visitors to the meeting. To request reasonable accommodation, please contact the CMS Reasonable Accommodation Program at Email reasonableaccommodationprogram@ cms.hhs.gov. Participants who attended previous Coordination and Maintenance meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you wish attend. Please register to attend the meeting on-line at: http://www.cms.hhs.gov/ apps/events/. Please contact Mady Hue (410) 786– 4510 or Marilu.hue@cms.hhs.gov for questions about the registration process. Note: CMS and NCHS no longer provide paper copies of handouts for the meeting. Electronic copies of all meeting materials will be posted on the CMS and NCHS websites prior to the meeting at http:// www.cms.hhs.gov/ICD9ProviderDiagnostic Codes/03_meetings.asp#TopOfPage and https://www.cdc.gov/nchs/icd/icd10cm_ maintenance.htm. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\06FEN1.SGM 06FEN1

Agencies

[Federal Register Volume 84, Number 25 (Wednesday, February 6, 2019)]
[Notices]
[Page 2229]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01205]



[[Page 2229]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis (ACET) 
Meeting; Correction

    Notice is hereby given of a change in the meeting of the Advisory 
Council for the Elimination of Tuberculosis (ACET): December 11, 2018, 
8:30 a.m. to 4:30 p.m., EDT which was published in the Federal Register 
on November 2, 2018 Volume 83, Number 213, pages 55172.
    The time for December 11, 2018, 8:30 a.m. to 4:30 p.m., EST should 
read as follows: 10:00 a.m. to 4:30 p.m., EST.

FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee 
Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E-07, 
Atlanta, Georgia 30329, telephone (404) 639-8317; zkr7@cdc.gov.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-01205 Filed 2-5-19; 8:45 am]
 BILLING CODE 4163-18-P